Nomura Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228M Buy
1,776,387
+196,532
+12% +$23M 0.49% 34
2026
Q1
$190M Buy
1,579,855
+194,263
+14% +$22.4M 0.49% 30
2025
Q4
$146M Sell
1,385,592
-83,512
-6% -$7.84M 0.37% 45
2025
Q3
$123M Sell
1,469,104
-75,924
-5% -$6.25M 0.32% 53
2025
Q2
$122M Buy
1,545,028
+6,065
+0.4% +$482K 0.34% 55
2025
Q1
$138M Buy
1,538,963
+47,024
+3% +$4.39M 0.42% 43
2024
Q4
$148M Sell
1,491,939
-72,337
-5% -$7.46M 0.45% 39
2024
Q3
$178M Buy
1,564,276
+327,426
+26% +$38.9M 0.55% 31
2024
Q2
$154M Buy
1,236,850
+2,811
+0.2% +$362K 0.52% 33
2024
Q1
$163M Buy
1,234,039
+68,953
+6% +$8.5M 0.59% 27
2023
Q4
$127M Buy
1,165,086
+29,674
+3% +$3.08M 0.52% 34
2023
Q3
$117M Sell
1,135,412
-80,214
-7% -$8.65M 0.55% 32
2023
Q2
$140M Sell
1,215,626
-3,570
-0.3% -$405K 0.65% 26
2023
Q1
$130M Buy
1,219,196
+110,835
+10% +$12M 0.68% 24
2022
Q4
$123M Buy
1,108,361
+26,491
+2% +$2.71M 0.71% 25
2022
Q3
$93.2M Buy
1,081,870
+4,900
+0.5% +$437K 0.59% 30
2022
Q2
$98.2M Buy
1,076,970
+274,635
+34% +$24.3M 0.61% 29
2022
Q1
$65.8M Buy
802,335
+944
+0.1% +$74.4K 0.36% 61
2021
Q4
$61.4M Sell
801,391
-16,600
-2% -$1.32M 0.31% 76
2021
Q3
$61.4M Sell
817,991
-32,493
-4% -$2.47M 0.35% 70
2021
Q2
$66.1M Sell
850,484
-126,949
-13% -$9.44M 0.38% 60
2021
Q1
$71.9M Sell
977,433
-332,142
-25% -$24.5M 0.46% 44
2020
Q4
$102M Buy
1,309,575
+121,850
+10% +$9.32M 0.69% 25
2020
Q3
$94M Sell
1,187,725
-92,011
-7% -$7.21M 0.72% 22
2020
Q2
$94.4M Sell
1,279,736
-63,969
-5% -$4.82M 0.8% 19
2020
Q1
$98.7M Buy
1,343,705
+146,205
+12% +$11.5M 1.02% 12
2019
Q4
$104M Buy
1,197,500
+2,028
+0.2% +$167K 0.93% 15
2019
Q3
$96M Buy
1,195,472
+44,471
+4% +$3.56M 0.92% 17
2019
Q2
$92.1M Sell
1,151,001
-641,990
-36% -$49.2M 0.91% 17
2019
Q1
$142M Sell
1,792,991
-132,717
-7% -$9.93M 1.4% 8
2018
Q4
$140M Buy
1,925,708
+326,695
+20% +$23.1M 1.57% 6
2018
Q3
$108M Buy
1,599,013
+296,264
+23% +$18.9M 1.05% 18
2018
Q2
$75.5M Buy
1,302,749
+2,090
+0.2% +$118K 0.78% 24
2018
Q1
$67.6M Buy
1,300,659
+25,966
+2% +$1.4M 0.74% 30
2017
Q4
$68.4M Buy
1,274,693
+89,022
+8% +$4.94M 0.79% 27
2017
Q3
$72.4M Buy
1,185,671
+641,826
+118% +$38.9M 0.94% 20
2017
Q2
$33.3M Sell
543,845
-5,118
-0.9% -$312K 0.45% 55
2017
Q1
$33.3M Buy
548,963
+9,988
+2% +$606K 0.47% 52
2016
Q4
$30.3M Buy
538,975
+7,706
+1% +$451K 0.55% 41
2016
Q3
$31.6M Buy
531,269
+10,301
+2% +$602K 0.57% 41
2016
Q2
$28.6M Buy
520,968
+34,499
+7% +$1.84M 0.54% 45
2016
Q1
$24.6M Buy
486,469
+58,064
+14% +$2.84M 0.47% 53
2015
Q4
$21.6M Sell
428,405
-210,532
-33% -$10.6M 0.42% 64
2015
Q3
$30.1M Sell
638,937
-75,173
-11% -$3.99M 0.6% 35
2015
Q2
$38.8M Sell
714,110
-264,006
-27% -$14.8M 0.72% 30
2015
Q1
$53.6M Sell
978,116
-412,679
-30% -$23.4M 0.96% 13
2014
Q4
$76.4M Sell
1,390,795
-102,418
-7% -$5.71M 1.33% 8
2014
Q3
$84.1M Buy
1,493,213
+17,937
+1% +$1.01M 1.49% 6
2014
Q2
$81.4M Sell
1,475,276
-286,370
-16% -$15.6M 1.51% 6
2014
Q1
$95.3M Buy
1,761,646
+178,879
+11% +$9.26M 1.74% 4
2013
Q4
$75.6M Sell
1,582,767
-239,390
-13% -$10.9M 1.36% 11
2013
Q3
$82.8M Sell
1,822,157
-32,482
-2% -$1.48M 1.57% 6
2013
Q2
$82.2M Buy
+1,854,639
New +$82.8M 1.63% 5

Other funds holding MRK

Nomura Asset Management's MRK Position: Q2 2026 in Review

Nomura Asset Management increased its Merck (MRK) stake by 12% in Q2 2026, buying an estimated $23M and bringing the position to 1,776,387 shares worth $228M. The position accounts for 0.49% of the portfolio, ranked #34.

Nomura Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nomura Asset Management held 1,776,387 shares of Merck worth $228M as of Q2 2026.
  • Nomura Asset Management bought 196,532 Merck shares in Q2 2026, an estimated $23M.
  • Merck made up 0.49% of Nomura Asset Management's portfolio in Q2 2026, its #34 holding.
  • Nomura Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.